ロード中...
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Drug combination represents one of the most accredited strategies of cancer therapy able to improve drug efficacy and possibly overcome drug resistance. Among the agents used to complement conventional chemotherapy, carbonic anhydrase IX (CAIX) inhibitors appear as one of the most suitable, as marke...
保存先:
| 出版年: | J Enzyme Inhib Med Chem |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6211231/ https://ncbi.nlm.nih.gov/pubmed/30362384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2018.1532419 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|